Login to Your Account



Phenomix Getting $75M Up Front in Diabetes Deal with Forest Labs

By Catherine Hollingsworth


Friday, October 24, 2008
Phenomix Corp. and Forest Laboratories Inc. entered a deal to develop and commercialize oral diabetes drug candidate dutogliptin (PHX1149) in North America. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription